APA (7th ed.) Citation

J, O., I, O., & B, P. (2026). When, which and how to switch: Navigating JAK inhibitors in myelofibrosis. British journal of haematology, 208(2), 437. https://doi.org/10.1111/bjh.19929

Chicago Style (17th ed.) Citation

J, O'Sullivan, Omerdeen I, and Psaila B. "When, Which and How to Switch: Navigating JAK Inhibitors in Myelofibrosis." British Journal of Haematology 208, no. 2 (2026): 437. https://doi.org/10.1111/bjh.19929.

MLA (9th ed.) Citation

J, O'Sullivan, et al. "When, Which and How to Switch: Navigating JAK Inhibitors in Myelofibrosis." British Journal of Haematology, vol. 208, no. 2, 2026, p. 437, https://doi.org/10.1111/bjh.19929.